SAB Biotherapeutics Inc

Stock Chart, Company Information, and Scan Results

$3.99(as of Dec 16, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

SAB Biotherapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$3.99
Ticker SymbolSABS
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees63
CountyUSA
Market Cap$190.4M

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.

SAB Biotherapeutics Inc In Our Stock Scanner

As of Dec 17, 2025
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.